Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators - Top-Institutions - MDSpire

Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators

  • By

  • Kinga K. Tomczak

  • Jason P. Swindle

  • Firas M. Dabbous

  • Donald L. Gilbert

  • George B. Karkanias

  • Sarah D. Atkinson

  • Frederick E. Munschauer

  • Faizan Mazhar

  • Charlotte A. Pettersson

  • Stephen P. Wanaski

  • Timothy M. Cunniff

  • David A. Isaacs

  • June 2, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatrics
    • Neurology
  • #2

    Kennedy Krieger Institute/Johns Hopkins Medicine
    Kennedy Krieger Institute/Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Pediatrics
    • Neurology
    • Psychiatry
  • #3

    Child and Adolescent Twin Study in Sweden (CATSS)
    Child and Adolescent Twin Study in Sweden (CATSS)

    Gothenburg, Sweden

    Key Differentiators

    • Pediatrics
    • Psychiatry
  • #4

    University Hospital of Trieste
    University Hospital of Trieste

    Trieste, Italy

    Key Differentiators

    • Pediatrics
    • Neurology
  • #5

    University of Gothenburg
    University of Gothenburg

    Gothenburg, Sweden

    Key Differentiators

    • Pediatrics
    • Psychiatry

Original Source(s)

Related Content